SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7.76 |
Enterprise Value ($M) | 7.76 |
Book Value ($M) | 0.00 |
Book Value / Share | 0.00 |
Price / Book | n/a |
NCAV ($M) | 0.00 |
NCAV / Share | 0.00 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | n/a |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.00 |
Assets | 0.00 |
Liabilities | 0.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 32.31 |
Operating Income | -3.53 |
Net Income | -6.16 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 1.12 |
Cash from Investing | -0.04 |
Cash from Financing | -1.39 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
330 | 10,029 | 3.29 | |
6,198 | 34,378 | 18.03 | |
1,760 | 9,611 | 18.31 | |
12,777 | 39,454 | 32.38 | |
2,601 | 9,552 | 27.23 | |
(click for more detail) |
Similar Companies | |
---|---|
TRVN – Trevena, Inc. | TTNP – Titan Pharmaceuticals, Inc. |
UNCY – Unicycive Therapeutics, Inc. | UPXI – Upexi, Inc. |
VBIV – VBI Vaccines Inc. |
Financial data and stock pages provided by
Fintel.io